Skip to main content

Table 5 Encapsulation efficiency, loading capacity and Wight Yield % of CAF and FA

From: Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade

CAF-CS-NPs

FA-CS-NPs

CAF-FA-CS-NPs

CAF EE%

CAF LC%

CAF Wight Yield %

FA EE%

FA LC%

FA Wight Yield %

CAF EE%

CAF LC%

FA EE%

FA LC%

Mean of CAF, FA LC%

96.02 ± 0.4

45.8 ± 1.04

48%

98.6 ± 0.32

35.1 ± 0.76

50 ± 0.82%

98.5 ± 0.37

39.5 ± 0.51

77.8 ± 0.76

32.7 ± 0.25

36.5 ± 0.52